Atreca to Participate at Upcoming Virtual Investor Conferences
February 22 2021 - 4:30PM
Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage
biotechnology company focused on developing novel therapeutics
generated through a unique discovery platform based on
interrogation of the active human immune response, today announced
that it will participate in the following upcoming virtual investor
conferences:
Cowen 41st Annual Health Care ConferenceDate:
Monday, March 1, 2021Panel discussion time: 1:20 p.m. ESTTitle:
“Novel Oncology Targets”
H.C. Wainwright Global Life Sciences
ConferenceDate: Tuesday, March 9, 2021Presentation time:
7:00 a.m. EST
33rd Annual Roth
ConferenceDate: Tuesday, March 16, 2021Fireside chat time:
4:00 p.m. EDT
A live audio webcast of the H.C. Wainwright and Roth
presentations can be accessed through the Events &
Presentations section of the Company's website at ir.atreca.com. An
archived replay of both presentations will be available on the
Company's website for 90 days following the live event.
About Atreca, Inc.Atreca is a biopharmaceutical
company developing novel antibody-based immunotherapeutics
generated by its differentiated discovery platform. Atreca’s
platform allows access to an unexplored landscape in oncology
through the identification of unique antibody-target pairs
generated by the human immune system during an active immune
response against tumors. These antibodies provide the basis for
first-in-class therapeutic candidates, such as our lead product
candidate ATRC-101. A Phase 1b study evaluating ATRC-101 in
multiple solid tumor cancers is currently enrolling patients. For
more information on Atreca, please visit www.atreca.com.
Contacts
Atreca, Inc.Herb CrossChief Financial
Officerinfo@atreca.comInvestors:Alex Gray,
650-779-9251agray@atreca.com
Media:Sheryl Seapy, 213-262-9390sseapy@w2ogroup.com
Source: Atreca, Inc.
Atreca (NASDAQ:BCEL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Atreca (NASDAQ:BCEL)
Historical Stock Chart
From Sep 2023 to Sep 2024